Matthew Belvedere & Peter Schacknow |
In the news today |
---|
With just two trading days left in the third quarter, U.S. stock futures started off the week sharply lower following Friday’s big rally, which capped a volatile week of triple-digit moves up and down for the Dow. (CNBC)
Chicago Fed President Charles Evans joins CNBC's "Squawk Box" at 8 a.m. ET with his views on interest rates, the economy, and financial markets.
|
Adding to market uncertainties, pro-democracy protesters expanded their rallies throughout Hong Kong today—defying calls to disperse in a major pushback against Beijing's decision to limit democratic reforms in the Asian financial hub. (AP) | Live CNBC blog | Hong Kong stocks tanked. |
Friday's shock announcement that Pimco founder Bill Gross was leaving to join rival Janus Capital (JNS) has taken its toll on his former firm, with Deutsche Bank now expecting around $266 billion in outflows. (CNBC) |
A new breast cancer drug from Switzerland’s Roche (RHHBY) has shown "unprecedented" benefits in a clinical trial, and experts urged its widespread use for women with an aggressive form of the disease. (Reuters) |
An investigation of Apple’s (AAPL) tax affairs in Ireland by the European Commission is expected to result in the American tech giant being accused of prospering from illegal deals and facing a record fine. (FT) |
Microsoft (MSFT) CEO Satya Nadella is promising to cooperate fully with Chinese authorities in their antitrust investigation, following a meeting with a top regulator in Beijing. (Reuters) |
Japan's SoftBank is in talks to acquire DreamWorks Animation (DWA), the Hollywood studio behind the "Shrek" and "Madagascar" movie hits. The buyout terms under consideration would value DreamWorks at $3.4 billion.(Reuters) |
Facebook (FB) is making its long-anticipated move to grow its reach and take on Google's (GOOG) DoubleClick. The social network’s new Atlas advertiser tools were unveiled this morning. (CNBC) |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.